Results 171 to 180 of about 169,884 (264)

Diagnostic accuracy of the TrueNat™ MTB plus assay for detecting pulmonary tuberculosis in adults. [PDF]

PLoS One
Mallya SP, Mbelele PM, Mbelele PM, Kisonga RM, Mtunga DD, Banzi HH, Mpiima SS, Twinomujuni M, Bazira J, Kassaza K.   +9 more
europepmc   +1 more source

Evaluation of the Diagnostic Accuracy of the Quantitative Point‐of‐Care SD Biosensor Standard G6PD Test for Assessment of G6PD Deficiency in Infectious Diseases

International Journal of Laboratory Hematology, Volume 48, Issue 2, Page 440-446, April 2026.
ABSTRACT Background G6PD deficiency affects about 500 million people worldwide and is prevalent in many malaria‐endemic settings. People with G6PD deficiency are at risk of hemolysis when exposed to certain medications, including 8‐aminoquinoline drugs used to treat Plasmodium vivax malaria.
Flavia Regina Medeiros da Silva, Alexandre Gomes Vizzoni, Daniela Mendes‐de‐Almeida, Joanna Bokel, Raquel de Vasconcellos Carvalhaes de Oliveira, André Machado Siqueira, Yasmine Rangel Vieira, Simone da Costa Cruz Silva   +7 more
wiley   +1 more source

From Pulmonary Tuberculosis to Antineutrophil Cytoplasmic Antibody (ANCA) Seroconversion: A Case of Rapidly Progressive Glomerulonephritis. [PDF]

Cureus
AlShammari OA, Abuqurayn I, Kiran I, Almansour A, Almarzoqi M, Alazmi B, Bilal Delvi S, Comert A, Abotouk N, Bokhari R, Amatouq BA, Almane AA.   +11 more
europepmc   +1 more source

The Dual Immunoregulatory Role of CREB3L1 Underlying Latent and Severe Tuberculosis Clinical Manifestation

Immunology, Volume 177, Issue 4, Page 810-823, April 2026.
RNA‐seq of lungs and livers from Mycobacterium tuberculosis ‐infected mice with distinct disease outcomes revealed organ‐specific responses driven by differences in immune activity and bacterial burden. Meta‐analysis identified orthologous genes shared with human latent TB and mouse liver, with Creb3l1, Myo7b, Cyyr1 and Cbs differentially expressed and
Felipe T. Lima, Ricardo C. Castro, Francisco R. Javier, Caroline Fontanari, Valdes R. Bollela, Rogerio S. Rosada, Célio L. Silva, Lúcia H. Faccioli, Luiz G. Gardinassi, Fabiani G. Frantz   +9 more
wiley   +1 more source

Massive Hemoptysis Secondary to Rasmussen's Aneurysm in a Patient With Active Pulmonary Tuberculosis: A Case Report. [PDF]

Cureus
Farooqi W, Alosaimi N, Alsenaidi S, Almalik A, Alosaimi E.   +4 more
europepmc   +1 more source

Durvalumab combined with concurrent chemoradiotherapy in patients with limited‐stage small cell lung cancer: A prospective, single‐arm, phase 2 clinical trial

Cancer, Volume 132, Issue 6, 15 March 2026.
Abstract Background The current standard treatment for limited‐stage small cell lung cancer (LS‐SCLC) is concurrent chemoradiotherapy (cCRT) plus consolidation immunotherapy, with or without prophylactic cranial irradiation (PCI). However, it remains unknown whether administering immunotherapy concurrently with chemoradiotherapy confers additional ...
Chunyang Song, Xiaohan Zhao, Shuguang Li, Xuehan Guo, Xueyuan Zhang, Xiaobin Wang, Youmei Li, Ke Yan, Jingwei Su, Jinrui Xu, Shuchai Zhu, Wenbin Shen   +11 more
wiley   +1 more source

Mortality from cancer and non‐cancer diseases in the Lithuanian cohort of Chernobyl cleanup workers (2001–2020)

International Journal of Cancer, Volume 158, Issue 6, Page 1498-1506, 15 March 2026.
What's new? Following the Chernobyl disaster, workers were recruited from formerly Soviet‐occupied areas, including Lithuania, to participate in clean‐up efforts. Radiation exposure incurred by workers during these efforts offers a unique opportunity for the study of long‐term health effects.
Rita Steponaviciene, Ausrele Kesminiene, Auguste Kaceniene, Giedre Smailyte   +3 more
wiley   +1 more source

Prevalence of rifampicin resistance in pulmonary tuberculosis: A laboratory-based study. [PDF]

PLOS Glob Public Health
Bedzina I, Lartey ANL, Kwaley-Buabeng L, Mensah P, Nudo G, Odum ES, Sewornu R, Ablordey K, Deku JG, Duedu KO.   +9 more
europepmc   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, Volume 20, Issue 3, Page 629-636, March 2026.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source